This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Adeno‐associated virus (AAV)-based gene therapy for glioblastoma
Cancer Cell International Open Access 26 January 2021
-
Brainstem development requires galactosylceramidase and is critical for pathogenesis in a model of Krabbe disease
Nature Communications Open Access 23 October 2020
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Get just this article for as long as you need it
$39.95
Prices may be subject to local taxes which are calculated during checkout
References
Foust, K.D. et al. Nat. Biotechnol. 27, 59–65 (2009).
Ek, C.J. et al. J. Comp. Neurol. 460, 451–464 (2003).
Ek, C.J. et al. J. Comp. Neurol. 496, 13–26 (2006).
Lowenstein, P.R. Nat. Biotechnol. 27, 42–44 (2009).
Caley, W.D. & Maxwell, D.S. J. Comp. Neurol. 138, 31–48 (1970).
Saunders, N.R. et al. in Developmental Neurotoxicology (eds. Harry, J. & Tilson, H.) (Informa Health Care, New York, 2009).
Saunders, N.R. Handbook Exper. Pharmacol. 103, 327–369 (1992).
Saunders, N.R. et al. Trends Neurosci. 31, 279–286 (2008).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Saunders, N., Joakim Ek, C. & Dziegielewska, K. The neonatal blood-brain barrier is functionally effective, and immaturity does not explain differential targeting of AAV9. Nat Biotechnol 27, 804–805 (2009). https://doi.org/10.1038/nbt0909-804
Issue Date:
DOI: https://doi.org/10.1038/nbt0909-804
This article is cited by
-
Adeno‐associated virus (AAV)-based gene therapy for glioblastoma
Cancer Cell International (2021)
-
The deletion of mutant SOD1 via CRISPR/Cas9/sgRNA prolongs survival in an amyotrophic lateral sclerosis mouse model
Gene Therapy (2020)
-
Brainstem development requires galactosylceramidase and is critical for pathogenesis in a model of Krabbe disease
Nature Communications (2020)
-
MiR-298 Counteracts Mutant Androgen Receptor Toxicity in Spinal and Bulbar Muscular Atrophy
Molecular Therapy (2016)
-
Distinct transduction profiles in the CNS via three injection routes of AAV9 and the application to generation of a neurodegenerative mouse model
Molecular Therapy - Methods & Clinical Development (2014)